John D Quisel

CIK 1586788 · Chief Executive Officer · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$15.37M

Companies

3

Total Filings

60

Lifetime Open-Market Net

-$17.17M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GOSS Director $0.16 $0 4 2026-06-05
IRON Chief Executive Officer 226,064 $67.99 $15.37M -$9.97M 16 2026-02-17
ACCELERON PHARMA INC (XLRN) Delisted EVP, Chief Business Officer 57,558 $178.75 $10.29M -$7.20M 39 2020-01-03

Recent Filings · Page 2 of 6

60 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-02-20 IRON Sell (S) −5,574 -$304.2K EDGAR
2025-02-12 IRON Grant (A) +78,337 $0 EDGAR
2025-01-02 IRON Mixed +10,000 -$667.7K EDGAR
2024-12-26 IRON Mixed -$1.20M EDGAR
2024-12-18 IRON Mixed -$831.4K EDGAR
2024-07-10 IRON Exer (M) +3,000 $3.0K EDGAR
2024-06-06 GOSS Grant (A) $0 EDGAR
2024-03-01 IRON Grant (A) +66,365 $0 EDGAR
2024-01-03 IRON Exer (M) +2,700 $2.7K EDGAR
2023-11-29 GOSS Grant (A) $0 EDGAR
Showing 1120 of 60
Page 2 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.